Biofidelity wins Start Up of the Year at the Cambridge Independent Science & Technology Awards

Cambridge, UK 16 April 2021 – Biofidelity Ltd, the cancer diagnostics company, today announced it has won Start Up of the Year at the Cambridge Independent Science & Technology Awards. 

We are delighted and honoured to be recognised among this strong core of innovative and dynamic companies. This award highlights the hard work and commitment from the team at Biofidelity to bring the company so quickly to where it is today. In the last year, we have grown from five people to 25, raised $12 million, employed some fantastic key hires, and recently had both our first peer reviewed publication and several key patents granted. Our vision is to revolutionise access to best-in-class cancer diagnostics to ensure that every single patient can receive the right treatment at the right time. Building on our recent success, we are excited to see what 2021 brings for us.
Dr. Barnaby Balmforth
Chief Executive Officer at Biofidelity

About the Cambridge Independent Science and Technology Awards

The Cambridge Independent Science and Technology Awards, now in their fourth year, celebrate the talent and achievements of the science and technology sectors across the Cambridge UK region. 

For further information, please go to https://www.cambridgeindependent.co.uk/business/winners-of-cambridge-independent-science-and-technology-awar-9195718/